Published in Cancer on July 15, 2004
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol (2011) 2.85
Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev (2009) 2.50
Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2008) 2.44
Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev (2005) 2.11
Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer (2008) 2.03
Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis (2011) 1.84
Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis (2010) 1.83
Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 1.68
Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst (2012) 1.67
Updating the natural history of human papillomavirus and anogenital cancers. Vaccine (2012) 1.65
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer (2012) 1.63
Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health (2010) 1.53
Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia. PLoS One (2013) 1.45
Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer (2006) 1.33
Changing patterns of anal canal carcinoma in the United States. J Clin Oncol (2013) 1.23
Management of anal squamous intraepithelial lesions. Clin Colon Rectal Surg (2009) 1.14
An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer (2009) 1.14
Anal cancer - a review. Int J Health Sci (Qassim) (2012) 1.01
Gay and bisexual men's willingness to receive anal Papanicolaou testing. Am J Public Health (2010) 1.00
Anal cancer treatment: current status and future perspectives. World J Gastroenterol (2015) 0.97
Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior. Cancer Epidemiol Biomarkers Prev (2015) 0.97
Dubowitz syndrome is a complex comprised of multiple, genetically distinct and phenotypically overlapping disorders. PLoS One (2014) 0.95
Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men. J Acquir Immune Defic Syndr (2009) 0.94
Anal cancer in renal transplant patients. Int J Colorectal Dis (2005) 0.94
Anal cancer screening behaviors and intentions in men who have sex with men. J Gen Intern Med (2008) 0.94
Prospects for prevention of HPV-driven oropharynx cancer. Oral Oncol (2013) 0.92
Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica. J Infect Dis (2012) 0.92
Regional and national guideline recommendations for digital ano-rectal examination as a means for anal cancer screening in HIV positive men who have sex with men: a systematic review. BMC Cancer (2014) 0.91
Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men. Cytojournal (2006) 0.90
HPV Carcinomas in Immunocompromised Patients. J Clin Med (2015) 0.90
Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand. Sex Transm Infect (2009) 0.88
Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIV-negative men who have sex with men. PLoS One (2014) 0.87
Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal. Clin Colon Rectal Surg (2011) 0.87
Anal screening cytology. Cytojournal (2005) 0.87
Quality of life outcomes in patients with anal cancer after combined radiochemotherapy. Strahlenther Onkol (2011) 0.87
Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced? Strahlenther Onkol (2009) 0.86
Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis. Radiat Oncol (2014) 0.86
The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series. J Oncol (2011) 0.86
FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy. Br J Cancer (2011) 0.86
HPV infections among MSM in Shenzhen, China. PLoS One (2014) 0.86
Anal cancer incidence and survival: comparing the greater San-Francisco bay area to other SEER cancer registries. PLoS One (2013) 0.85
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experience. Am J Clin Oncol (2011) 0.85
HPV-associated Oropharyngeal Cancers--Are They Preventable? Cancer Prev Res (Phila) (2011) 0.85
Prevalence of Anal Human Papillomavirus Infection and Risk Factors among HIV-positive Patients in Tokyo, Japan. PLoS One (2015) 0.84
Reasons for delays in diagnosis of anal cancer and the effect on patient satisfaction. Can Fam Physician (2015) 0.84
Uptake and predictors of anal cancer screening in men who have sex with men. Am J Public Health (2013) 0.84
Cervical and anal human papillomavirus infection in adult women in American Samoa. Asia Pac J Public Health (2012) 0.84
Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations. Open AIDS J (2007) 0.84
Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy. BMC Cancer (2015) 0.83
A regimen of taxol, Ifosfamide, and platinum for recurrent advanced squamous cell cancer of the anal canal. Chemother Res Pract (2011) 0.83
Anal cancer incidence and mortality in Puerto Rico. P R Health Sci J (2013) 0.82
Inhibition of mTOR reduces anal carcinogenesis in transgenic mouse model. PLoS One (2013) 0.82
Why are we not screening for anal cancer routinely - HIV physicians' perspectives on anal cancer and its screening in HIV-positive men who have sex with men: a qualitative study. BMC Public Health (2015) 0.82
Definitive chemoradiation in oligometastatic squamous cell carcinoma of the anal canal. Gastrointest Cancer Res (2014) 0.81
Metastatic squamous cell carcinoma of the anus: time for a shift in the treatment paradigm? ISRN Oncol (2012) 0.81
Presenting symptoms predict local staging of anal cancer: a retrospective analysis of 86 patients. BMC Gastroenterol (2016) 0.81
Human papillomavirus vaccination: current indications and future directions. Obstet Gynecol Clin North Am (2013) 0.81
Anal cytological abnormalities and epidemiological correlates among men who have sex with men at risk for HIV-1 infection. BMC Cancer (2012) 0.80
Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012. PLoS One (2015) 0.80
Addressing anal health in the HIV primary care setting: a disappointing reality. AIDS Patient Care STDS (2010) 0.80
Surgical treatment for isolated inguinal lymph node metastasis in lower rectal adenocarcinoma patients improves outcome. Int J Colorectal Dis (2013) 0.80
Current treatment options for management of anal intraepithelial neoplasia. Onco Targets Ther (2013) 0.80
FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma. Radiat Oncol (2010) 0.80
A Community-Based Approach to Enhancing Anal Cancer Screening in Hawaii's HIV-Infected Ethnic Minorities. J AIDS Clin Res (2012) 0.80
Tobacco smoking and risk of recurrence for squamous cell cancer of the anus. Cancer Detect Prev (2008) 0.80
Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study. Dis Colon Rectum (2014) 0.79
Technical aspects of radiation therapy for anal cancer. J Gastrointest Oncol (2014) 0.79
Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease. Clin Transl Gastroenterol (2016) 0.79
Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal. Oncologist (2015) 0.78
Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget (2015) 0.78
Radiological assessment of anal cancer: an overview and update. Infect Agent Cancer (2016) 0.78
Anal cancer treated with radio-chemotherapy: correlation between length of treatment interruption and outcome. Int J Colorectal Dis (2009) 0.78
Clinical experience of SIB-IMRT in anal cancer and selective literature review. Radiat Oncol (2014) 0.78
A combined modality therapeutic approach to metastatic anal squamous cell carcinoma with systemic chemotherapy and local therapy to sites of disease: case report and review of literature. J Gastrointest Oncol (2016) 0.78
Anal dysplasia screening: an evidence-based analysis. Ont Health Technol Assess Ser (2007) 0.78
Biomarkers in anal cancer: from biological understanding to stratified treatment. Br J Cancer (2016) 0.77
Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma. Int J Colorectal Dis (2011) 0.77
The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin. Radiol Oncol (2016) 0.77
The role of Human Papilloma Virus (HPV) vaccination in the prevention of anal cancer in individuals with Human Immunodeficiency Virus-1 (HIV-1) infection. Ther Adv Vaccines (2013) 0.77
Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292). Int J Radiat Oncol Biol Phys (2011) 0.76
Diagnostic performance of positron emission tomography/computed tomography using fluorine-18 fluorodeoxyglucose in detecting locoregional nodal involvement in patients with anal canal cancer: a systematic review and meta-analysis. ScientificWorldJournal (2014) 0.75
French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients. Radiat Oncol (2015) 0.75
Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy era. Curr Opin HIV AIDS (2017) 0.75
A comparison between 5-fluorouracil/mitomycin and capecitabine/mitomycin in combination with radiation for anal cancer. J Gastrointest Oncol (2016) 0.75
Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer. Oncotarget (2017) 0.75
Human papillomavirus in anal squamous cell carcinoma: an angel rather than a devil? Ecancermedicalscience (2015) 0.75
The burden of HPV associated cancers in two regions in Nigeria 2012-2014. Cancer Epidemiol (2016) 0.75
Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples. J Clin Microbiol (2014) 0.75
A wide field-of-view scanning endoscope for whole anal canal imaging. Biomed Opt Express (2015) 0.75
Anal Squamous Cell Carcinoma in African Americans with and without HIV: A Comparative Study. J Cancer Epidemiol Treat (2015) 0.75
Brain metastasis in basaloid undifferentiated anal carcinoma: A case report. Oncol Lett (2014) 0.75
Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center. J Gastrointest Oncol (2015) 0.75
Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology. Viruses (2015) 0.75
Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis. Ecancermedicalscience (2016) 0.75
The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer. Oncologist (2016) 0.75
Uncertainty Abounds in the World of Anal Dysplasia Screening. Sex Transm Dis (2016) 0.75
Surveillance of anal carcinoma after radiochemotherapy : A retrospective analysis of 80 patients. Strahlenther Onkol (2017) 0.75
Racial Disparity in Gastrointestinal Cancer Risk. Gastroenterology (2017) 0.75
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet (2012) 12.10
Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet (2010) 7.08
Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med (2003) 6.47
A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31
New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet (2009) 5.12
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Intern Med (2013) 4.36
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer (2009) 4.28
Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer (2004) 4.04
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst (2003) 3.44
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. Cell Stem Cell (2008) 3.18
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol (2003) 3.05
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet (2009) 2.85
Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res (2004) 2.80
Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer (2005) 2.79
Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet (2005) 2.71
Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer (2008) 2.56
Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol (2011) 2.52
Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev (2002) 2.50
Relationship between potentially modifiable lifestyle factors and risk of second primary contralateral breast cancer among women diagnosed with estrogen receptor-positive invasive breast cancer. J Clin Oncol (2009) 2.44
Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control (2007) 2.36
The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet (2005) 2.26
Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA (2003) 2.24
Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst (2009) 2.22
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice: potential role of chondrocyte-like cells. Arterioscler Thromb Vasc Biol (2005) 2.18
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Recruitment and follow-up of adolescent and young adult cancer survivors: the AYA HOPE Study. J Cancer Surviv (2011) 2.15
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res (2010) 2.14
Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc (2003) 2.11
A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomarkers Prev (2008) 2.10
Body mass index, weight, and oral contraceptive failure risk. Obstet Gynecol (2005) 2.07
Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev (2009) 2.00
Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: a SEER-Medicare database study. Cancer Epidemiol (2013) 1.99
Total exposure and exposure rate effects for alcohol and smoking and risk of head and neck cancer: a pooled analysis of case-control studies. Am J Epidemiol (2009) 1.97
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation (2011) 1.96
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med (2007) 1.94
Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control (2007) 1.92
Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol (2002) 1.92
A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol (2002) 1.90
Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.88
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol (2006) 1.86
Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med (2002) 1.85
A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol (2004) 1.85
Effect of prediagnostic alcohol consumption on survival after breast cancer in young women. Cancer Epidemiol Biomarkers Prev (2008) 1.83
A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J Natl Cancer Inst (2002) 1.83
Breast cancers among very young premenopausal women (United States). Cancer Causes Control (2003) 1.80
Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst (2005) 1.75
Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet (2013) 1.74
Arterial remodeling in [corrected] subclinical carotid artery disease. JACC Cardiovasc Imaging (2009) 1.74
Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Am J Epidemiol (2013) 1.73
Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol (2009) 1.70
A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68
Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev (2007) 1.67
A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet (2011) 1.63
Characteristics of telephone survey respondents according to willingness to participate. Am J Epidemiol (2003) 1.63
Do thyroid disorders increase the risk of breast cancer? Cancer Epidemiol Biomarkers Prev (2002) 1.62
Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2009) 1.62
Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.60
Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2002) 1.60
Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev (2013) 1.59
Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev (2005) 1.59
Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril (2003) 1.58
Survival following parathyroidectomy among United States dialysis patients. Kidney Int (2004) 1.57
Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review. Am J Epidemiol (2004) 1.56
Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer (2006) 1.56
Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.53
Feasibility of including cellular telephone numbers in random digit dialing for epidemiologic case-control studies. Am J Epidemiol (2010) 1.52
The sex ratio of pregnancies complicated by hospitalisation for hyperemesis gravidarum. BJOG (2004) 1.51
Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med (2005) 1.51
Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis (2012) 1.48
Reproductive factors and risk of breast carcinoma in a study of white and African-American women. Cancer (2004) 1.46
A short acculturation scale for Mexican-American populations. Ethn Dis (2005) 1.45
Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS One (2008) 1.42
Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res (2008) 1.40
Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.39
Association of history of allergies and influenza-like infections with laryngeal cancer in a case-control study. Eur Arch Otorhinolaryngol (2015) 1.39
Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. Am J Epidemiol (2002) 1.39